China Pharma Holdings Inc. (CPHI)
NYSE · Healthcare
China Pharma Holdings Inc. EBITDA 2010–2025
China Pharma Holdings Inc. annual/quarterly ebitda history and growth rate from 2010 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- China Pharma Holdings Inc. ebitda for the quarter ending March 31, 2026 was -136694, a 68.16% decrease year-over-year.
- China Pharma Holdings Inc. ebitda for the twelve months ending March 31, 2026 was -465850, a 244.01% decrease year-over-year.
- China Pharma Holdings Inc. annual ebitda for 2025 was -1.7 M, a 11.94% decrease from 2024.
- China Pharma Holdings Inc. annual ebitda for 2024 was -2.0 M, a 107617.73% decrease from 2023.
- China Pharma Holdings Inc. annual ebitda for 2023 was 1833, a 100.22% decrease from 2022.
- China Pharma Holdings Inc. annual ebitda for 2022 was -848444.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
China Pharma Holdings Inc. EBITDA — FAQ
China Pharma Holdings Inc. (CPHI) ebitda over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CPHI's ebitda history?
The chart and table above show China Pharma Holdings Inc.'s ebitda by year and by quarter, including the growth rate.